The Daily Start-Up: Amgen agrees to acquire KAI Pharmaceuticals
Amgen has announced it will acquire KAI Pharmaceuticals in a $315 million cash transaction, giving the drug maker rights to an experimental drug to treat chronic kidney disease.... [more]
